Clinical Trial Update: LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media [NA]

View source ↗

Summary

A ClinicalTrials.gov update reports the completion of a study evaluating LiveSpo Navax for acute rhinosinusitis and otitis media within upper respiratory tract …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media
• Rhinosinusitis
• Upper Respiratory Tract Infection

Drugs mentioned

• LiveSpo Navax

Snippet

Sponsor: Anabio R&D | Conditions: Upper Respiratory Tract Infections | NA | Status: COMPLETED